Market IntelligenceJune 29, 202512 min read How to Value a Founder-Owned Pharma Business in India
What the Torrent-JB Chemicals Deal Actually Tells You
KKR turned a Rs. 3,100 Cr pharma acquisition into a Rs. 25,689 Cr exit in five years. Here is what the 24.8x EBITDA Torrent-JB Chemicals deal means for founder-owned pharma businesses in India — and how to close the valuation gap before you engage a bank.
Read Article →